NEW YORK, Aug. 7, 2015 /PRNewswire/ -- Morgan &
Morgan announces that it is investigating potential claims against
the board of directors of Merge Healthcare Incorporated ("Merge
Healthcare" or the "Company") (MRGE) concerning possible breaches
of fiduciary duty and other violations of law related to the
Company's efforts to sell the Company to IBM in a transaction
valued at approximately $1
billion.
If you own shares of Merge Healthcare and would like to
learn more about the Merge Healthcare shareholder investigation,
you may contact Morgan & Morgan at 1(800) 732-5200 or email
info@morgansecuritieslaw.com.
Under the terms of the transaction, Merge shareholders will
receive $7.13 in cash for each share
of Merge they own. The investigation relates to whether the
proposal is fair to the public shareholders and if the
Company's Board of Directors breached their fiduciary duties to
shareholders.
About Morgan & Morgan
Morgan & Morgan is one of the nation's largest 200 law
firms. In addition to shareholder rights, the firm also practices
in the areas of antitrust, personal injury, consumer protection,
overtime, and product liability. All of the Firm's legal
endeavors are rooted in its core mission: provide investor and
consumer protection and always fight "for the people."
Attorney advertising. Prior results do not guarantee a similar
outcome.
Contact:
Morgan & Morgan
Peter Safirstein, Esq.
28 West 44th Street
Suite 2001
New York, NY 10036
1-800-732-5200
info@morgansecuritieslaw.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/morgan--morgan-announces-the-investigation-of-merge-healthcare---mrge-300125715.html
SOURCE Morgan & Morgan
